Clinical Trials · NCT00529204
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of California, Davis
- Enrollment
- 1
- Start date
- Oct 2007
- Locations
- 1 site, United States
- Primary endpoint
- Reduction in Serum ALT From Baseline to 24 Weeks of Exenatide Therapy